메뉴 건너뛰기
Lancet Neurology
Volumn 3, Issue 12, 2004, Pages 704-
Intravenous immunoglobulins for Alzheimer's disease
Author keywords

[No Author keywords available]
Indexed keywords

AMYLOID BETA PROTEIN; ANTIGEN; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2 INHIBITOR; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;
EID: 8844256204     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00929-9     Document Type: Letter
Times cited : (8)
References (9)
  • 1
    • 0016849288 scopus 로고
    • Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique
    • Ishii T, Haga S. Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique. Acta Neuropathol (Berl). 32:1975;157-162
    • (1975) Acta Neuropathol (Berl) , vol.32 , pp. 157-162
    • Ishii, T.1    Haga, S.2
  • 2
    • 0023796433 scopus 로고
    • Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease
    • Foley P, Bradford HF, Docherty M, et al. Evidence for the presence of antibodies to cholinergic neurons in the serum of patients with Alzheimer's disease. J Neurol. 235:1988;466-471
    • (1988) J Neurol , vol.235 , pp. 466-471
    • Foley, P.1    Bradford, H.F.2    Docherty, M.3
  • 3
    • 0242268945 scopus 로고    scopus 로고
    • Immunotherapeutic approaches to Alzheimer's disease
    • Monsonego A, Weiner HL. Immunotherapeutic approaches to Alzheimer's disease. Science. 302:2003;834-838
    • (2003) Science , vol.302 , pp. 834-838
    • Monsonego, A.1    Weiner, H.L.2
  • 4
    • 0141453824 scopus 로고    scopus 로고
    • The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease
    • Aisen PS. The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease. Lancet Neurol. 1:2002;279-284
    • (2002) Lancet Neurol , vol.1 , pp. 279-284
    • Aisen, P.S.1
  • 5
    • 4644337032 scopus 로고    scopus 로고
    • Intravenous immunoglobulins: A treatment for Alzheimer's disease?
    • Hack CE, Scheltens P. Intravenous immunoglobulins: a treatment for Alzheimer's disease? J Neurol Neurosurg Psychiatry. 75:2004;1374-1375
    • (2004) J Neurol Neurosurg Psychiatry , vol.75 , pp. 1374-1375
    • Hack, C.E.1    Scheltens, P.2
  • 6
    • 0037452779 scopus 로고    scopus 로고
    • Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology
    • Bard F, Barbour R, Cannon C, et al. Epitope and isotype specificities of antibodies to beta-amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci USA. 100:2003;2023-2028
    • (2003) Proc Natl Acad Sci USA , vol.100 , pp. 2023-2028
    • Bard, F.1    Barbour, R.2    Cannon, C.3
  • 7
    • 2942739009 scopus 로고    scopus 로고
    • Autoimmunity in Alzheimer's disease: Increased levels of circulating IgGs binding Abeta and RAGE peptides
    • Muthinti S, Buccafusco JJ, Hill WD, et al. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging. 25:2004;1023-1032
    • (2004) Neurobiol Aging , vol.25 , pp. 1023-1032
    • Muthinti, S.1    Buccafusco, J.J.2    Hill, W.D.3
  • 8
    • 0037223101 scopus 로고    scopus 로고
    • Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid
    • Matsuoka Y, Saito M, LaFrancois J, et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci. 23:2003;29-33
    • (2003) J Neurosci , vol.23 , pp. 29-33
    • Matsuoka, Y.1    Saito, M.2    Lafrancois, J.3
  • 9
    • 4644275963 scopus 로고    scopus 로고
    • Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease
    • Dodel RC, Du Y, Depboylu C, et al. Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 75:2004;1472-1474
    • (2004) J Neurol Neurosurg Psychiatry , vol.75 , pp. 1472-1474
    • Dodel, R.C.1    Du, Y.2    Depboylu, C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.